|
|
Volumn 5, Issue 1, 2010, Pages 39-52
|
|
Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
PHARMACOLOGICAL BIOMARKER;
CAPILLARY PERMEABILITY;
DIFFUSION WEIGHTED IMAGING;
DRUG EFFECT;
HUMAN;
MAGNETIC RESONANCE ANGIOGRAPHY;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
PATHOLOGY;
PROGNOSIS;
REVIEW;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC AGENTS;
BIOMARKERS, PHARMACOLOGICAL;
CAPILLARY PERMEABILITY;
DIFFUSION MAGNETIC RESONANCE IMAGING;
HUMANS;
MAGNETIC RESONANCE ANGIOGRAPHY;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
PROGNOSIS;
MLCS;
MLOWN;
|
|
EID: 77956929983
PISSN: None
EISSN: 1776260X
Source Type: Journal
DOI: 10.1007/s11523-010-0135-8 Document Type: Review |
|
Times cited : (91)
|
|
References (105)
|
